Australia
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
318.27 |
Jan. 14, 2025 | USD 1.58 | -2.06% |
|
Australia |
|
2 |
154.14 |
Jan. 14, 2025 | USD 157.25 | 0.24% |
|
Australia |
|
3 |
98.37 |
Jan. 14, 2025 | USD 2.37 | 1.84% |
|
Australia |
|
4 |
77.08 |
Jan. 14, 2025 | USD 5.88 | 0.14% |
|
Australia |
|
5 |
21.70 |
Jan. 14, 2025 | USD 0.74 | -1.40% |
|
Australia |
|
6 |
15.30 |
Jan. 14, 2025 | USD 15.47 | 4.25% |
|
Australia |
|
7 |
13.15 |
Jan. 14, 2025 | USD 1.33 | 6.17% |
|
Australia |
|
8 |
7.45 |
Jan. 14, 2025 | USD 1.27 | -1.68% |
|
Australia |
|
9 |
6.19 |
Jan. 14, 2025 | USD 7.32 | 6.16% |
|
Australia |
|
10 |
5.64 |
Jan. 14, 2025 | USD 173.13 | 0.11% |
|
Australia |
|
11 |
5.41 |
Jan. 14, 2025 | USD 2.01 | -0.68% |
|
Australia |
|
12 |
2.15 |
Jan. 14, 2025 | USD 1.81 | -0.10% |
|
Australia |
|
13 |
1.90 |
Jan. 14, 2025 | USD 21.11 | 1.40% |
|
Australia |
|
14 |
1.72 |
Jan. 14, 2025 | USD 3.89 | 3.70% |
|
Australia |
|
15 |
1.72 |
Jan. 14, 2025 | USD 0.76 | 1.07% |
|
Australia |
|
16 |
1.64 |
Jan. 14, 2025 | USD 1.21 | 0.76% |
|
Australia |
|
17 |
1.39 |
Jan. 14, 2025 | USD 17.28 | 1.26% |
|
Australia |
|
18 |
1.32 |
Jan. 14, 2025 | USD 1.81 | -0.44% |
|
Australia |
|
19 |
1.20 |
Jan. 14, 2025 | USD 2.35 | 0.77% |
|
Australia |
|
20 |
1.12 |
Jan. 14, 2025 | USD 0.71 | 1.12% |
|
Australia |
|
21 |
0.92 |
Jan. 14, 2025 | USD 2.14 | 0.82% |
|
Australia |
|
22 |
0.91 |
Jan. 14, 2025 | USD 0.62 | -2.68% |
|
Australia |
|
23 |
0.87 |
Jan. 14, 2025 | USD 2.80 | 2.04% |
|
Australia |
|
24 |
0.79 |
Jan. 14, 2025 | USD 0.84 | -1.22% |
|
Australia |
|
25 |
0.54 |
Jan. 14, 2025 | USD 0.87 | 0.96% |
|
Australia |
|
26 |
0.45 |
Jan. 14, 2025 | USD 20.43 | 1.47% |
|
Australia |
|
27 |
0.44 |
Jan. 14, 2025 | USD 21.27 | 2.57% |
|
Australia |
The Health Care company in Australia with the highest Price to Sales Ratio (P/S) is Mesoblast Limited (ASX: MSB.AX) at 318.27.
The Health Care company in Australia with the lowest Price to Sales Ratio (P/S) is Ramsay Health Care Limited (ASX: RHC.AX) at 0.44.
The top 10 Health Care companies in Australia by Price to Sales Ratio (P/S) are Mesoblast Limited, Pro Medicus Limited, Clarity Pharmaceuticals Ltd, Anteris Technologies Ltd, PYC Therapeutics Limited, Telix Pharmaceuticals Limited, PolyNovo Limited, Cyclopharm Limited, Clinuvel Pharmaceuticals Limited and CSL Limited.
The bottom 10 Health Care companies in Australia by Price to Sales Ratio (P/S) are Ramsay Health Care Limited, EBOS Group Limited, Healius Limited, Viva Leisure Limited, Mayne Pharma Group Limited, Trajan Group Holdings Limited, Australian Clinical Labs Limited, SDI Limited, Medibank Private Limited and Sigma Healthcare Limited.